| Literature DB >> 31906055 |
Fatin Aina Zulkhairi Amin1, Suriana Sabri2,3, Maznah Ismail1, Kim Wei Chan1, Norsharina Ismail1, Norhaizan Mohd Esa1,4, Mohd Azmi Mohd Lila5, Norhasnida Zawawi1,6.
Abstract
This study aimed to isolate, identify, and evaluate the probiotic properties of Bacillus species from honey of the stingless bee Heterotrigona itama. Bacillus spp. were isolated from five different H. itama meliponicultures, and the isolates were characterized through Gram-staining and a catalase test. Tolerance to acidic conditions and bile salt (0.3%), hydrophobicity, and autoaggregation tests were performed to assess the probiotic properties of the selected isolates, B. amyloliquefaciens HTI-19 and B. subtilis HTI-23. Both Bacillus isolates exhibited excellent antimicrobial activity against both Gram-positive and Gram-negative bacteria and possessed significantly high survival rates in 0.3% bile solution for 3 h. Their survival rates in acidic conditions were also comparable to a commercial probiotic strain, Lactobacillus rhamnosus GG. Interestingly, the hydrophobicity and autoaggregation percentage showed no significant difference from L. rhamnosus GG, a commercial probiotic strain. The results from this study suggest that B. amyloliquefaciens HTI-19 and B. subtilis HTI-23 isolated from stingless bee honey have considerably good probiotic properties. Therefore, more studies should be done to investigate the effects of these bacteria cultures on gastrointestinal health.Entities:
Keywords: antimicrobial activity; molecular identification; pathogenic bacteria; probiotic Bacillus strains; stingless bee honey
Mesh:
Year: 2019 PMID: 31906055 PMCID: PMC6981522 DOI: 10.3390/ijerph17010278
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Preliminary selection of Bacillus strains isolated from stingless bee honey from different geographical locations. CFU: colony-forming unit.
| Geographical Location | CFU/g | No. of Selected Isolates | Gram-Staining | Catalase Test | Tolerance to 7% NaCl | ||||
|---|---|---|---|---|---|---|---|---|---|
| Gram + ve | Gram − ve | Bacilli | Cocci | +ve | −ve | ||||
| Batang Benar, Negeri Sembilan | 2.2 × 102 | 17 | 17 | - | 17 | - | All isolates exhibited positive results for catalase test | 6 | |
| Segamat, Johor | 2.4 × 102 | 23 | 21 | 2 | 23 | - | 9 | ||
| Seri Kembangan, Selangor | 1.1 × 101 | 3 | 3 | - | 3 | - | 2 | ||
| Sematan, Sarawak | 9.7 × 100 | 4 | 3 | 1 | 3 | 1 | 3 | 2 | 2 |
| Serdang, Selangor | 3.7 × 102 | 11 | 11 | - | 11 | - | 6 | 5 | 4 |
| TOTAL | 23 | ||||||||
Figure 1Evolutionary relationships of taxa. The evolutionary history was inferred using the neighbor-joining method. An optimal tree with the sum of branch lengths = 0.34080293 is shown. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) is shown next to the branches. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the maximum composite likelihood method and are in the units of the number of base substitutions per site. The analysis involved 32 nucleotide sequences. All positions containing gaps and missing data were eliminated. There were a total of 1405 positions in the final dataset. Evolutionary analyses were conducted in MEGA7.
Figure 2Distribution of the Bacillus species isolated from stingless bee (Heterotrigona itama) honey from different geographical locations.
Antagonistic activities of Bacillus species against six different pathogenic bacteria.
| Bacterial Isolates | Inhibition Zones against Pathogenic Bacteria, mm | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| +++ | NI | NI | NI | NI | NI | |
| +++ | NI | NI | NI | NI | NI | |
| NI | NI | NI | NI | NI | NI | |
| ++ | NI | NI | NI | + | NI | |
| ++ | NI | NI | NI | NI | NI | |
| +++ | NI | NI | NI | NI | NI | |
| +++ | ++ | NI | NI | ++ | NI | |
| +++ | NI | NI | NI | NI | NI | |
| NI | NI | NI | NI | NI | ++ | |
| +++ | NI | NI | NI | NI | NI | |
| +++ | NI | NI | NI | NI | NI | |
| NI | NI | NI | NI | NI | NI | |
| NI | NI | NI | NI | NI | NI | |
| NI | NI | NI | NI | NI | NI | |
| +++ | ++ | ++ | ++ | NI | + | |
| +++ | NI | NI | +++ | NI | NI | |
| NI | NI | NI | NI | NI | NI | |
| NI | NI | NI | NI | NI | NI | |
| + | NI | +++ | NI | ++ | ++ | |
| +++ | +++ | +++ | +++ | ++ | +++ | |
| Tetracycline(20ug/µl) | +++ | +++ | +++ | +++ | +++ | +++ |
Note: clear zone around well; +: 1–3 mm; ++: 3–5 mm; +++: >5 mm; NI: no inhibition zone was detected.
Figure 3Inhibition zone of (a) potential probiotic B. amyloliquefaciens HTI-19 (HTI-19) against Staphylococcus aureus and (b) commercial probiotic Lactobacillus rhamnosus GG (LGG) against S. aureus.
The survival of selected probiotic Bacillus isolates in simulated gastrointestinal conditions.
| Isolates | Survival Rates, % | |
|---|---|---|
| Acid Tolerance | Bile Tolerance | |
| pH 2.0 | 0.3% | |
| 86.56 a | 129.10 a | |
| 86.72 a | 140.50 b | |
| 97.46 b | 106.76 c | |
a–c: Different superscript letters in the same column indicate statistical differences in each strain at the level of p < 0.05 as measured by Tukey’s test. All the results were obtained after 3 h, and the values are represented as mean SDs of three independent replicates.
Cell adhesion activity of selected probiotic species.
| Isolates | Autoaggregation (%) | Hydrophobicity (%) |
|---|---|---|
| 84.13 a | 53.64 a | |
| 57.51 b | 60.82 a | |
| 69.99 ab | 61.04 a |
a,b: Different superscript letters in the same column indicate statistical differences in each strain at the level of p < 0.05 as measured by Tukey’s test. All the values are represented as mean SDs of three independent replicates.
Antibiotic susceptibility of Bacillus isolates to antibiotics. Antibiotics: AMP10 (ampicillin, 10 μg); C30 (chloramphenicol, 30 μg); CIP5 (ciprofloxacin, 15 μg); E15 (erythromycin, 15 μg); CN10 (gentamicin, 10 μg); K30 (kanamycin, 30 μg); TE30 (tetracycline, 30 μg); TEC30 (teicoplanin, 30 μg); VA30 (vancomycin, 30 μg); RD30 (rifampicin, 30 μg); and S10 (streptomycin, 10 μg). R: resistant; S: susceptible.
| Isolates | Susceptibility to Antibiotics | Hemolytic Activity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMP10 | C30 | CIP5 | E15 | CN10 | K30 | TE30 | TEC30 | VA30 | RD30 | S10 | ||
| S | S | S | S | S | S | S | S | S | S | S | α-hemolytic | |
| S | S | S | S | S | S | S | S | S | S | S | γ-hemolytic | |
| S | S | S | S | S | S | S | R | R | S | S | γ-hemolytic | |